Making noise in the quiet period May 31, 2019 by Michael

New Post Public Reply Private Reply Replies (0) Message Board
jrt03
434
Making noise in the quiet period
May 31, 2019 by Michael Fox, ICR
Recently, two high profile companies – Slack and Uber – were examples of how not to handle PR during an IPO. Both companies had to amend their S-1 SEC filings because of unsanctioned board member interviews on CNBC that included commentary that was either not company authorized or inconsistent with its filings.

The amended filings included transcripts of the interviews and disclaimers that the company did not sanction or endorse the comments.

In the worst case, these sort of missteps can result in an SEC-mandated cooling off period requiring the company to push its IPO plans back a few months. That may not sound like a big deal, but the fragile capital markets are always only one disruptive event away from closing up on new offerings, and missing an open window could result in a lengthy delay.

Apart from SEC action, these missteps reflect a sloppiness that can cause investors to wonder if the company is ready for the intense scrutiny of the public markets.

The quiet period. The SEC requires that when a company begins the IPO process it operates in what is called a quiet period. The beginning of that process is generally defined as the point at which the company retains investment bankers for the IPO.

Like most government regulations, the official definition of quiet period is about as clear as mud. But it generally means that all relevant information about the company of interest to potential investors be contained entirely in one place – the Prospectus (S-1 filing), that the SEC reviews and approves.

Any new and material information the company provides elsewhere at this time (e.g., in a media interview or conference presentation) is considered a violation. Even confidential employee communications are subject to these guidelines, as was witnessed in 2011 when Groupon was sanctioned (for a second time) by the SEC for financial claims made by CEO, Andrew Mason in an internal memo.

What is permitted. The quiet period does not mean companies must refrain from speaking at all during this time, which can last 3 to 4 months. They couldn’t effectively operate if that were the case. So what can they do and where are the boundaries?

For starters, companies are allowed to continue normal course of business communication which generally covers basic external marketing and typical internal communication. But it also underscores why it is important to establish a practice of active communication before the IPO.

If you don’t regularly send out press releases or do media interviews around product announcements, data reports, new hires or other basic company developments, it’s tough to claim they were normal course of business communications during a quiet period.

What is not permitted. More importantly, the SEC is concerned about what is said and who is saying it. The primary restrictions concern any substantive commentary about the business, its performance or financial results, future prospects or major developments such as new customers, updates on litigation, entering new markets, etc.

All of that information needs to be contained in the S-1. Anything that is not should not be discussed publicly.

While some companies will publicly acknowledge they are in the IPO process (even if their filing is still confidential), it is generally frowned upon to comment on the offering itself. And the comments of company executives and board members are particularly scrutinized.

It is critical that companies going through an IPO educate their executive team and board — and all employees once the IPO is made public — about the rules and restrictions on communication.

Spokespeople engaging in media interviews or speaking at public events must be coached very carefully on how to answer questions and avoid commenting on topics that will get them in trouble. For senior executives that is nearly impossible, so they should refrain from interviews prior to the IPO.

Listing day interviews. After the pricing and listing of the stock, the company remains in a quiet period for another few weeks. But it has become customary for CEOs to participate in listing day interviews. They’re a great way, using the IPO as credibility and a branding moment, to educate customers and investors.

But in this still-sensitive quiet period, they require skill and preparation. Here are a few tips:

First, carefully prepare for interviews with a comprehensive Q&A session that anticipates the questions common to IPO interviews. Also, plan for questions that cross the line (e.g., "We’ve stated X in our filing, and we look forward to updating investors and the public in the future."

Be sure the planned responses (and all key messaging) are aligned with the prospectus. Prepare for the media to ask questions about the risk factors highlighted in the prospectus and develop responses that communicate how the company is mitigating those risks.

Consult with company counsel as well as the underwriters and underwriters’ counsel when deciding whether to pursue listing day interviews prior to when the stock trading has begun. And prepare to give the same interview whether the stock trades up 50% or down 50%.

Communicate the company’s long-term growth strategy as outlined in the prospectus, with listing day as the beginning of the next chapter of growth, regardless of where the stock priced or is trading.

Limit the total number of interviews and spokespeople, to ensure messaging stays tight. Remember, the IPO follows a grueling two week roadshow and the management team will be exhausted.

Know your interviewer and make sure they are informed about the company in advance and don’t forget — stick to the script.

The last thing you want to do in these interviews is create news. The IPO is the news and it speaks for itself. The interview is simply an opportunity to guide the narrative, inform the story and shine a brighter light on the IPO.

An IPO is one of the most important and exciting corporate events a company will experience and it should be celebrated loudly and proudly. But it has to be managed within the rules laid out by regulators.

Careful advanced planning and experienced execution can help companies achieve maximum brand exposure without stepping out of line.

Michael Fox is the chief client officer for ICR and has advised clients on more than 150 IPOs in his career.

https://www.prweek.com/article/1585205/making...iet-period

Univec Conglomerate Inc (UNVC) Stock Research Links

UNVC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 282

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 308

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 243

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 281

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 462

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 303

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 421

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 594

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 547

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 505

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading

Top 5 Most Recently Viewed Articles

Shuttle Pharma Sets Stage With Major $5.75 Million Offering

Updated Category News Views 118

Shuttle Pharma Secures $5.75 Million in Public Offering Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) has made an impactful announcement that reflects its commitment to advancing cancer treatment. The company, recognized for its innovative approach to enhancing the efficacy of radiation therapy for cancer patients, has confirmed the pricing of its latest public...

Continue Reading
Innovative B2B Marketplace Development Announced by INNO Holdings

Updated Category News Views 133

Strategic Partnership Announcement INNO HOLDINGS INC. (“INNO” or the “Company”) (NASDAQ: INHD), a prominent player in the technology and electronic products trading sector, proudly unveils its strategic collaboration with New Life Technology Development Co Ltd (“New Life Tech”). This innovative partnership aims to revolutionize the B2B marketplace platform, a...

Continue Reading
Thomasville Bancshares, Inc. Celebrates Milestone Growth in 2024

Updated Category News Views 145

Strong Financial Performance Marks 2024 for Thomasville Bancshares Thomasville Bancshares, Inc. (OTC PINK: THVB), which serves as the parent company for Thomasville National Bank and TNB Financial Services, has reported impressive financial results for the year ending December 31, 2024. The company demonstrated remarkable growth and solid financial health, underlining its...

Continue Reading
EchoStar's Earnings Anticipation: Insights and Stock Analysis

Updated Category News Views 138

EchoStar's Earnings Predictions EchoStar (NASDAQ: SATS) is preparing for its quarterly earnings announcement, and investors are keenly awaiting the details. As this announcement approaches, it's essential to understand the key financial metrics and expectations to guide investment decisions. Understanding EPS Estimates Analysts project that EchoStar will report an...

Continue Reading
Luminary Labs Secures Contract to Enhance Federal Innovations

Updated Category News Views 155

Luminary Labs Secures Contract to Enhance Federal Innovations Luminary Labs, a strategy and innovation consultancy, has been awarded a prestigious contract under OASIS+ Small Business. This "Best-in-Class" contract vehicle is designed to simplify access for federal clients seeking strategic partnerships. The contract reveals Luminary Labs' commitment and expertise in...

Continue Reading